The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age

被引:54
作者
Krogsgaard, Laura Rindom [1 ]
Engsbro, Anne Line [1 ]
Bytzer, Peter [1 ]
机构
[1] Koge Univ Hosp, Dept Med Gastroenterol, Koge, Denmark
关键词
epidemiology; functional gastrointestinal disorder; irritable bowel syndrome; prevalence; Rome criteria; Rome III criteria; ROME III CRITERIA; PRIMARY-CARE; PREVALENCE; METAANALYSIS; SYMPTOMS; MANAGEMENT; DISORDERS; STABILITY; PATTERNS; SUBTYPES;
D O I
10.3109/00365521.2013.775328
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective. Our aims were to investigate the prevalence and subtype distribution of irritable bowel syndrome (IBS) according to the Rome III criteria in Denmark, to describe the difference in symptom reporting between those with gastrointestinal (GI) symptoms not fulfilling Rome III for IBS compared to those classified as IBS, and furthermore to describe the proportion of consulters and formally diagnosed subjects. Material and methods. A web-based survey was carried out in January 2010. Questionnaires were emailed to a web panel (n = 19,567) representative of the general Danish population aged 18-50 years on gender, age, and geography. IBS and subtypes were estimated by the Rome III criteria. Results. Of 6112 responders, 979 (16%) fulfilled the Rome III criteria for IBS and had no organic diagnosis likely to explain their symptoms. Subtypes were: mixed IBS 36%, IBS with diarrhea 33%, IBS with constipation 18%, and unsubtyped IBS 11%. Those with GI symptoms, not fulfilling Rome III for IBS, had symptoms very similar to those classified as IBS, but symptoms were less frequent and of shorter duration. Of IBS subjects, 180/978 (18.4%) had consulted a doctor for GI symptoms within the past 3 months, but only 7.9% were diagnosed with IBS. Conclusion. Symptoms compatible with IBS according to Rome III are highly prevalent in Denmark. A high proportion of sufferers are undiagnosed.
引用
收藏
页码:523 / 529
页数:7
相关论文
共 23 条
[1]  
Begtrup LM, 2013, CLIN GASTRO IN PRESS
[2]   Irritable bowel syndrome in primary care: The patients' and doctors' views on symptoms, etiology and management [J].
Bijkerk, CJ ;
de Wit, NJ ;
Stalman, WAB ;
Knottnerus, JA ;
Hoes, AW ;
Muris, JWM .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 17 (06) :363-368
[3]   GPs' explanatory models for irritable bowel syndrome: a mismatch with patient models? [J].
Casiday, Rachel E. ;
Hungin, A. P. S. ;
Cornford, Charles S. ;
de Wit, Niek J. ;
Blell, Mwenza T. .
FAMILY PRACTICE, 2009, 26 (01) :34-39
[4]   Irritable Bowel Syndrome Subtypes Defined by Rome II and Rome III Criteria are Similar [J].
Dorn, Spencer D. ;
Morris, Carolyn B. ;
Hu, Yuming ;
Toner, Brenda B. ;
Diamant, Nicholas ;
Whitehead, William E. ;
Bangdiwala, Shrikant I. ;
Drossman, Douglas A. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (03) :214-220
[5]   A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator [J].
Drossman, DA ;
Morris, CB ;
Hu, YM ;
Toner, BB ;
Diamant, N ;
Leserman, J ;
Shetzline, M ;
Dalton, C ;
Bangdiwala, SI .
GASTROENTEROLOGY, 2005, 128 (03) :580-589
[6]   The Rome II and Rome III criteria identify the same subtype-populations in irritable bowel syndrome: agreement depends on the method used for symptom report [J].
Engsbro, A. L. ;
Simren, M. ;
Bytzer, P. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (07) :604-e266
[7]   Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification [J].
Engsbro, A. L. ;
Simren, M. ;
Bytzer, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (03) :350-359
[8]  
Engsbro AL, 2012, NEUROGASTROENT MOTIL, V24, pe266
[9]   Change over time of bowel habit in irritable bowel syndrome:: a prospective, observational, 1-year follow-up study (RITMO study) [J].
Garrigues, V. ;
Mearin, F. ;
Badia, X. ;
Balboa, A. ;
Benavent, J. ;
Caballero, A. ;
Dominguez, E. ;
Diaz-Rubio, M. ;
Roset, M. ;
Figueras, M. ;
Cucala, M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (03) :323-332
[10]   Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact [J].
Hungin, APS ;
Chang, L ;
Locke, GR ;
Dennis, EH ;
Barghout, V .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (11) :1365-1375